EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 30-Apr-2025 10:08 ET (30-Apr-2025 14:08 GMT/UTC)

Americans are uninformed about and undervaccinated for HPV

University of Southern California - Health Sciences
Peer-Reviewed Publication

Research shows that HPV accounts for 70% of all throat cancers, but only one-third of the public is aware that HPV causes throat cancer

Finding innovative ways to address kidney cancer leads to DoD grant

Weill Cornell Medicine
Grant and Award Announcement

Weill Cornell Medicine has received a $1.4 million, four-year grant from the U.S. Department of Defense to investigate a new therapeutic approach for the most common form of kidney cancer.

Allostatic load, educational attainment, and risk of cancer mortality among us men

JAMA Network
Peer-Reviewed Publication

About The Study: This study highlights the detrimental association of not attaining a high school degree, combined with high allostatic load as a marker of chronic stress, with cancer mortality. Efforts to promote educational attainment and address the underlying social determinants of health are imperative in reducing cancer disparities in this population.

Journal: JAMA Network Open

Geriatric surgery verification program can improve outcomes for older cancer patients in community hospitals

American College of Surgeons
Peer-Reviewed Publication

Implementing the American College of Surgeons (ACS) Geriatric Surgery Verification (GSV) program leads to better postoperative outcomes and preserves independence in older cancer patients undergoing major abdominal procedures, according to a new study published in the Journal of the American College of Surgeons (JACS).

Journal: Journal of the American College of Surgeons

Cancer ‘fingerprint’ can improve early detection

Center for Genomic Regulation
Peer-Reviewed Publication

Different types of cancer have unique molecular ‘fingerprints’ which are detectable in early stages of the disease and can be picked up with near-perfect accuracy by small, portable scanners in just a few hours, according to a study published today in the journal Molecular Cell. The discovery by researchers at the Centre for Genomic Regulation (CRG) in Barcelona sets the foundation for creating new, non-invasive diagnostic tests that detect different types of cancer faster and earlier than currently possible.

Journal: Molecular Cell

Gene variant common in individuals of African ancestry may lead to reduced metabolism of the thiopurine class of drugs

Elsevier
Peer-Reviewed Publication

Mayo Clinic researchers found that a gene variant, the TPMT∗8 allele, is associated with reduced metabolism of the thiopurine class of drugs. TPMT∗8 is relatively common in individuals of African or African American descent. A novel study in The Journal of Molecular Diagnostics, published by Elsevier, details the researchers' goal to provide pharmacogenomic testing that can be used clinically to predict drug response that is beneficial to all patients, regardless of their ancestral background.

Journal: Journal of Molecular Diagnostics

Prostaglandin E2’s role in senescence and neoplastic escape in human keratinocytes

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY- December 10, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 21 on November 18, 2024, entitled, “Prostaglandin E2 regulates senescence and post-senescence neoplastic escape in primary human keratinocytes.”

Journal: Aging-US

St. Jude names Maria Megdal as executive vice president and chief administrative officer

St. Jude Children's Research Hospital
Business Announcement

Medgal will oversee departments vital to St. Jude operations. She previously led operations at major cancer centers in Boston and New York.

Autologous stem cell transplants do not improve survival for mantle cell lymphoma patients with undetectable MRD, clinical trial shows

ECOG-ACRIN Cancer Research Group
Reports and Proceedings

Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant (ASCT) for patients with mantle cell lymphoma (MCL) in remission following their initial treatment. The finding is from the phase 3 study EA4151, by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN), presented December 10th at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego.

Funder: NIH/National Cancer Institute

Rice’s Veiseh elected to the National Academy of Inventors

Rice University
Grant and Award Announcement

Rice bioengineer Omid Veiseh has been elected as a National Academy of Inventors Fellow, the highest professional distinction awarded to inventors.